Plain-English translation of NCT07038473 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is looking for early warning signs of type 1 diabetes in children and teenagers whose parents, siblings, or other close relatives have already been diagnosed with the condition. Researchers will use blood tests to check for autoantibodies—substances your immune system makes when it starts attacking the cells that produce insulin—before any symptoms show up. Finding these signs early could help doctors understand who is at highest risk and potentially intervene sooner.
Type 1 diabetes often develops without warning, but there is a window of time before symptoms appear when the immune system is already attacking insulin-producing cells. This study exists to standardize early screening and monitoring in the Gulf region, so families with a history of type 1 diabetes can be identified and tracked before the disease becomes active.
You likely qualify if…
You likely don't qualify if…
You will visit the study clinic twice over about 13 months. At your first visit, researchers will take a blood sample to test for autoantibodies. If your results show autoantibodies, you'll return for a second visit where they'll repeat the autoantibody test, check your blood sugar control with another blood test, and possibly monitor your glucose levels with a continuous glucose monitor or a glucose tolerance test. The entire process is non-invasive and focused on detection, not treatment.
AI-generated summary from trial data · Aug 25, 2026 · Not medical advice
Kuwait
Saudi Arabia